| Followers | 144 |
| Posts | 27997 |
| Boards Moderated | 4 |
| Alias Born | 02/07/2004 |
Saturday, July 11, 2020 9:38:09 AM
One other Israeli stock worth looking into
is BCLI.
Latest PR:
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
PR Newswire PR Newswire•July 2, 2020
Topline data expected in 4Q 2020
https://finance.yahoo.com/news/brainstorm-announces-completion-dosing-nurown-104900360.html
BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
Zacks Small Cap Research Zacks Small Cap Research•July 9, 2020
https://finance.yahoo.com/news/bcli-kol-event-gives-overview-131000758.html
I think that the treshhold to obtain FDA approval is quite
low considering the gravity of the ALS disease.
is BCLI.
Latest PR:
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
PR Newswire PR Newswire•July 2, 2020
Topline data expected in 4Q 2020
https://finance.yahoo.com/news/brainstorm-announces-completion-dosing-nurown-104900360.html
BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
Zacks Small Cap Research Zacks Small Cap Research•July 9, 2020
https://finance.yahoo.com/news/bcli-kol-event-gives-overview-131000758.html
I think that the treshhold to obtain FDA approval is quite
low considering the gravity of the ALS disease.
Recent SLGL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 09:16:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 09:14:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:06 AM
- Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering • GlobeNewswire Inc. • 03/24/2026 01:38:22 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/19/2026 09:03:09 PM
- Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 • GlobeNewswire Inc. • 03/19/2026 12:53:28 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/19/2026 12:51:43 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 07:12:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:26:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:24:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:20:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:18:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:15:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 11:11:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 11:21:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 12:41:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/15/2026 11:54:30 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 01:47:45 PM
- Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease • GlobeNewswire Inc. • 12/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 01:44:10 PM
- Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/20/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/14/2025 11:00:31 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2025 06:12:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2025 11:00:10 AM
- Sol-Gel Announces Health Canada Approval of EPSOLAY® • GlobeNewswire Inc. • 09/04/2025 11:00:00 AM
